Word

LUMIRADX

Status

Registered

Status Code

700

Status Date

Tuesday, December 14, 2021

Serial Number

87400539

Registration Number

6585617

Registration Date

Tuesday, December 14, 2021

Mark Type

3000

Filing Date

Thursday, April 6, 2017

Published for Opposition

Tuesday, September 28, 2021

Trademark Owner History

LumiraDX International Ltd - Original Registrant

Classifications

10 Diagnostic, examination and monitoring equipment, namely, equipment for detecting and monitoring chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; medical instruments for use in detecting chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; apparatus for analyzing substances for medical use, namely, apparatus for analyzing biological substances for the presence, absence, or quantity of target chemicals and biologics; medical diagnostic apparatus for testing glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs and detecting chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; medical apparatus for monitoring vital signs; medical apparatus for use in analyzing glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs; automatic analyzers for testing and analysing biological substances for the presence, absence, or quantity of target chemicals and biologics for medical diagnosis; diagnostic apparatus for medical purposes; diagnostic imaging apparatus for medical use; diagnostic instruments for medical use, namely, for the testing and analysis of assays; diagnostic measuring apparatus for medical use, namely, apparatus for measuring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs; electromedical diagnostic instruments, namely, instruments for detecting chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; electronic apparatus for medical purposes, namely, apparatus for detecting, measuring and monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs, chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; electronic medical instruments used for detecting, measuring and monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs, chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology and drugs of abuse; electronic monitoring instruments for medical use used to monitor glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs, chronic diseases, infectious diseases, genetic disorders and conditions,cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology and drugs of abuse; medical analysis instruments used for testing and analysing biological substances for the presence, absence, or quantity of target chemicals and biologics; medical apparatus and instruments used for detecting, measuring and monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs, chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology and drugs of abuse; medical apparatus for detecting and measuring substances in the nature of target chemicals and biologics in bodily fluids; medical diagnostic apparatus used for detecting chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; medical diagnostic instruments used for detecting chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; medical imaging apparatus; medical testing instruments used to test glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs and detection of chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drug abuse; scanners for medical diagnosis; sensor apparatus used for sensing weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio and vital signs for medical use in diagnosis; medical diagnostic testing instruments used for detecting chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse for medical diagnostic purposes; trace material analyzers for use in diagnosis of chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drug abuse

44 Healthcare services; medical services; advisory services relating to medical apparatus and instruments for detecting, measuring and monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs, chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; compilation of medical reports designed to provide patients and healthcare professionals with customized diagnostic information, patient diagnoses, medical treatment plans and healthcare management plans; consultancy and information services relating to medical products for detecting, measuring and monitoring glucose levels, weight, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, vital signs, chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, hematology, and drugs of abuse; consultancy services in the field of health; consultancy services relating to diagnostic preparations for medical purposes; consultancy services relating to medical diagnostic apparatus and instruments; drug, alcohol and DNA screening for medical purposes; maintaining personal medical history records and files; medical analysis services, namely, providing medical record analysis and assessment services designed to provide patients and healthcare professionals with customized diagnostic information, patient diagnoses, medical treatment plans and healthcare management plans; medical diagnostic testing services; medical health assessment services; medical information; medical information retrieval services for the purpose of providing patients and healthcare professionals with diagnostic information and patient diagnoses; medical information services; medical screening; medical diagnosis and treatment of chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, and drug abuse; medical testing; online health and medical services, namely, providing an interactive database for exchanging information between a medical device user and healthcare providers, delivered via a global computer network; providing news and information in the field of medicine; providing online medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnosis and therapies associated with defined set of symptoms other than dentistry; rental of apparatus and installations in the field of medical technology; rental of medical and health care equipment; services for the preparation of medical reports, namely, providing patients and healthcare professionals with customized diagnostic reports, medical treatment plans and healthcare management plans; services for the provision of medical care information, namely, providing patients and healthcare professionals with customized plans for the treatment and management of chronic diseases, infectious diseases, genetic disorders and conditions, cardiovascular diseases and conditions, diabetes, cancer, pregnancy and prenatal conditions, sexually transmitted diseases, and drug abuse; telemedicine services; providing advice, consultancy and information on all of the aforesaid services

Color is not claimed as a feature of the mark.
The mark consists of an image of a flame beside the word "LUMIRADX".

Trademark Events

Dec 14, 2021

Registered-Principal Register

Sep 28, 2021

Official Gazette Publication Confirmation E-Mailed

Sep 28, 2021

Published For Opposition

Sep 8, 2021

Notification Of Notice Of Publication E-Mailed

Aug 26, 2021

Electronic Record Review Complete

Aug 20, 2021

On Hold - Electronic Record Review Required

Aug 16, 2021

1(B) Basis Deleted; New Basis Requested

Apr 12, 2021

Notice Of Allowance Cancelled

Jun 18, 2021

Notice Of Reinstatement E-Mailed

Jun 14, 2021

Petition To Director - Change Basis - Granted

Jun 14, 2021

Reinstated

Jun 14, 2021

Abandonment - No Use Statement Filed

Jun 10, 2021

Assigned To Petition Staff

Jun 10, 2021

Corrected Noa E-Mailed

Jun 9, 2021

Divisional Processing Complete

Apr 12, 2021

Divisional Request Received

May 26, 2021

Case Assigned To Intent To Use Paralegal

Apr 12, 2021

Teas Request To Divide Received

Apr 12, 2021

Teas Petition To Director Received

Apr 7, 2021

Assignment Of Ownership Not Updated Automatically

Oct 21, 2020

Notice Of Approval Of Extension Request E-Mailed

Oct 20, 2020

Extension 5 Granted

Oct 9, 2020

Extension 5 Filed

Oct 19, 2020

Case Assigned To Intent To Use Paralegal

Oct 9, 2020

Teas Extension Received

Apr 9, 2020

Notice Of Approval Of Extension Request E-Mailed

Apr 7, 2020

Extension 4 Granted

Apr 7, 2020

Extension 4 Filed

Apr 7, 2020

Teas Extension Received

Oct 12, 2019

Notice Of Approval Of Extension Request E-Mailed

Oct 10, 2019

Extension 3 Granted

Oct 10, 2019

Extension 3 Filed

Oct 10, 2019

Teas Extension Received

Apr 11, 2019

Notice Of Approval Of Extension Request E-Mailed

Apr 9, 2019

Extension 2 Granted

Apr 9, 2019

Extension 2 Filed

Apr 9, 2019

Teas Extension Received

Sep 29, 2018

Notice Of Approval Of Extension Request E-Mailed

Sep 27, 2018

Extension 1 Granted

Sep 27, 2018

Extension 1 Filed

Sep 27, 2018

Teas Extension Received

Apr 10, 2018

Noa E-Mailed - Sou Required From Applicant

Feb 13, 2018

Official Gazette Publication Confirmation E-Mailed

Feb 13, 2018

Published For Opposition

Jan 24, 2018

Notification Of Notice Of Publication E-Mailed

Dec 27, 2017

Approved For Pub - Principal Register

Dec 27, 2017

Teas/Email Correspondence Entered

Dec 27, 2017

Correspondence Received In Law Office

Dec 27, 2017

Teas Response To Office Action Received

Jun 28, 2017

Notification Of Non-Final Action E-Mailed

Jun 28, 2017

Non-Final Action E-Mailed

Jun 28, 2017

Non-Final Action Written

Jun 28, 2017

Assigned To Examiner

Apr 13, 2017

Notice Of Design Search Code E-Mailed

Apr 12, 2017

New Application Office Supplied Data Entered In Tram

Apr 10, 2017

New Application Entered In Tram